Based on a patented technology and with the support of its formulation expert subsidiary, Adisseo has developed a unique process which allows to get premium quality powder at 88% potency. Additional benefits such as improved anti-oxidation and anti-microbial effects will also be available to powder users. The mechanical characteristics, flowability and homogeneity in particular, of Rhodimet® A-Dry+ are optimized to match best-in-class in the market enabling superior performance in mixability, a key criteria for powder users.

Rhodimet® A-Dry+ is expected to be launched in the market early 2018. A new production unit implementing this new technology is currently being built on the Burgos site in Spain and expected to be commissioned by the end 2017. Its design has integrated the full value of Sustainable Development and the project has involved significant expertise from the Company in order to get minimal impact to the environment.

Jean-Marc Dublanc, CEO of Adisseo Group and the company, commented, 'we are delighted to come to the market with a true innovation. For all customers already fully convinced about the HMTBA benefits, we now can offer two products with same specificatons (88% potency) either in powder or in liquid form, so that they can make a choice that suits their facilities best as well as maximize the benefits and improve cost efficiency.'

In addition, the success of Rhodimet® AT88 in recent years (+50% since 2013) has fostered the need to accelerate the capacity extension project in Spain.

Adisseo has already announced its EUR110 million project into two existing sites in Europe - adding a third production line in Burgos, Spain, and implementing an investment program to upgrade its upstream facility of Les Roches, France, in order to sustain the development of the Burgos site. This project will increase the site competitiveness in many aspects, making it one of the best of its kind in the industry.

This extension will provide additional volume to serve the development of liquid sales (Rhodimet® AT88) and the new powder Rhodimet® A-Dry+.

'With the capacity extension program, we are one step closer to fully realizing the potential of our existing facilities so as to support the growth of our customers and to meet their request for a high quality and cost efficient source of methionine, therefore, to reinforce our industry leadership, especially in methionine market,' added Jean-Marc Dublanc.

As one of the two global methionine producers capable of producing methionine in both powder and liquid forms, Adisseo has cutting-edge manufacturing processes with one of the lowest cost on HMTBA. In 2015, Adisseo is the market leader in liquid methionine and the second largest player in global methionine industry by capacity and its market share in methionine products reached 27%.

Bluestar Adisseo Nutrition Group Limited published this content on 13 January 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 18 January 2017 09:21:03 UTC.

Original documenthttp://www.bluestar-adisseo.com/en/index.php/news_detail/id/81

Public permalinkhttp://www.publicnow.com/view/8FF500334F6DFA5AD67C38D4A85502D3C31FD1C8